Cita APA

Vici, P., Brandi, M., Giotta, F., Foggi, P., Schittulli, F., Di Lauro, L., . . . Lopez, M. (2012). A multicenter phase III prospective randomized trial of high-dose epirubicin in combination with cyclophosphamide (EC) versus docetaxel followed by EC in node-positive breast cancer. GOIM (Gruppo Oncologico Italia Meridionale) 9902 study. Oxford University Press.

Chicago Style Citation

Vici, P., et al. A Multicenter Phase III Prospective Randomized Trial of High-dose Epirubicin in Combination With Cyclophosphamide (EC) Versus Docetaxel Followed By EC in Node-positive Breast Cancer. GOIM (Gruppo Oncologico Italia Meridionale) 9902 Study. Oxford University Press, 2012.

Cita MLA

Vici, P., et al. A Multicenter Phase III Prospective Randomized Trial of High-dose Epirubicin in Combination With Cyclophosphamide (EC) Versus Docetaxel Followed By EC in Node-positive Breast Cancer. GOIM (Gruppo Oncologico Italia Meridionale) 9902 Study. Oxford University Press, 2012.